Terms ending in 2032
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,045,417 | Isotopologues of Isoindole Derivatives In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,642,836 | Isotopologues of Isoindole Derivatives In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 8,637,500 | Aminopyridine and Carboxypyridine Compounds as Phosphodiesterase 10 Inhibitors In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,517,264 | Human FGF Receptor and Beta-Klotho Binding Proteins In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 8,853,175 | Phenethylsulfone Isoindoline Derivatives and Their Use In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,296,698 | Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 8,962,859 | Spiro-Amino-Imidazo-Fused Heterocyclic Compounds as Beta-Secretase Modulators and Methods of Use In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 9,803,019 | Carrier Immunoglobulins and Uses Thereof In force · Medium confidence | Amgen Inc. | In force | Medium confidence | |
| US 9,133,272 | Bispecific Binding Agents In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,134,652 | Human CGRP Receptor Binding Proteins In force · Medium confidence | Amgen Inc. | In force | Medium confidence | |
| 77 more term ends in 2032 · Pro | |||||
10 of 87 patents shown. Soonest term end first, then patent number.
Pro members see all 87.
85 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.